These results reveal TFRC as a key effector through which NEDD4L regulates ferroptosis and suggest targeting the NEDD4L-TFRC interaction may have therapeutic potential for mitigating iron-mediated brain injury after stroke. Here, TFRC is linked to stroke disorder.